Pharma

sarepta building
Favicon Fierce Pharma

FDA backtracks on Sarepta's gene therapy Elevidys in DMD

The agency said that it had concluded that the death of an 8-year-old was not related to Elevidys but addressed none of the three prior deaths.
Angus Liu Jul 28, 2025 6:02pm
Closeup of blue eye on black background

Boehringer pens $1B pact to reduce eye drug injections

Jul 28, 2025 8:48am
colorful brain art model

Atai's schizophrenia drug fails to improve cognition in phase 2

Jul 28, 2025 7:45am
An arrow incrementally going up stairs before pointing straight up Blue background

Celcuity's breast cancer combo hits goals, teeing up FDA filing

Jul 28, 2025 6:00am
Lung

GSK strengthens COPD offering via $12B biobucks Hengrui deal

Jul 28, 2025 4:36am
Human kidney anatomy

Memo pushes kidney drug to phase 3 despite primary endpoint miss

Jul 25, 2025 5:30am